Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Nathan H. Heller

27 indexed publications match this author name.

ORCID: 0009-0009-1715-3699
OpenAlex: https://openalex.org/A5059281857

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 15 Clinical Trial 10 Mechanism of Action 10 Aging 9 Review Article 9 Receptor Pharmacology 9 Safety 9 Treatment-Resistant Depression 8 Brain Imaging 8 Observational Study 5 Animal Study 5 Adverse Events 4

Journals

PsyArXiv 6 Psychopharmacology 3 Journal of affective disorders 3 The Journal of clinical psychiatry 2 Neuroscience Applied 2 Journal of Affective Disorders 1 American journal of psychotherapy 1 Journal of eating disorders 1

Publication history

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01 Provider perspectives on challenges in treatment during psychedelic therapy.Psychopharmacology · 2026-07-01 Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28 Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15 The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.American journal of psychotherapy · 2025-12-15 Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".Journal of eating disorders · 2025-12-04 Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.Schizophrenia bulletin · 2025-10-06 Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15 Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15 Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-29 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03 The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01 Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-13 Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.The Journal of clinical psychiatry · 2025-02-05 Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.Psychedelics · 2025-01-01 Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.bioRxiv: the preprint server for biology · 2024-05-15 Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.Journal of psychiatric research · 2023-05-01 Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14 347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-10 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03 Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30 Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30 Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.Psychopharmacology · 2022-06-01 The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01 The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01 Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or PanaceaPsychiatric News · 2021-11-29 Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.Proceedings of the National Academy of Sciences of the United States of America · 2020-02-04

Author directory